Skip to main navigation
Skip to search
Skip to main content
Search by expertise, name or affiliation
Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) Scientific Meeting
Acute Lymphoblastic Leukamia (ALL) Research Group
Tavakoli PS, Eadie LN, Heatley SL, White DL.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Christchurch, New Zealand
13 Jun 2019
15 Jun 2019